No Data
Fosun Pharmacy (06086) released its interim performance, with a net loss of 0.819 billion yuan, an increase of 432% year-on-year.
Fangzhou Jianke (06086) announced its six-month performance ending on June 30, 2024, with revenue of 1.323 billion yuan...
Express News | Fangzhou Inc - Revenue Increased by 2.5% to RMB1,322.8 Mln for Six Months
FANGZHOU JIANKE: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
Ark Health Company (06086): Wu Xiuwei has been appointed as Co-Secretary of the company.
Arkpharm (06086) has announced that Feng Baoting has resigned as the Co-Secretary of the Company and the Company Secretary with effect from... due to work transfer.
Ark Pharmacy (06086.HK) will hold a board of directors meeting on August 28 to approve the interim performance.
On August 16th, Gelonhui announced that Ark Pharmacy (06086.HK) will convene a board meeting on August 28th, 2024 to consider and approve the mid-term performance of the company and its affiliates for the six months ending June 30th, 2024, as well as to consider distributing interim dividends (if any).
ARK Pharmacies Limited (06086.HK) plans to hold a board of directors meeting on August 28 to approve its mid-year performance.
Ark Pharmacy (06086.HK) announced on August 16th that the company will hold a board of directors meeting on Wednesday, August 28, 2024, to consider and approve the company and its subsidiaries' six-month interim performance as of June 30th, 2024, and its publication, including the consideration of distributing interim dividends (if any), and handling other matters.
No Data
